O-acetylation mediates four distinct structural variants of the pneumococcal vaccine serotype 15A capsule polysaccharide
The Journal of Infectious Diseases · 10.11.2026
DOI: 10.1093/infdis/jiag551 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 10.11.2026. Verfasst von Kyle J Sahlberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Streptococcus pneumoniae vaccine efforts rely on serological or molecular typing schemes to categorize over 100 biochemically distinct capsule polysaccharides (cPS) produced by the pathobiont; however, conventional approaches can fail to capture variations in key cPS biochemical features, such O-acetylation (OAc) patterns. The non-acetylated serotype 15A cPS is included in newer pneumococcal conjugate vaccine formulations and has one characterized acetylated counterpart, 15F. Report of a potential second variant “15D” prompted re-investigation of serogroup 15 capsule types.
Methods
We analyzed the cPS of serogroup 15 pneumococcal isolates and isogenic recombinant strains whose capsule synthesis loci vary by integrity of putative O-acetyltransferase (OAcT) genes wcjE or wciZ. cPS biochemical structures were compared in nuclear magnetic resonance and serotyping experiments. Computational analysis screened for novel serogroup 15 OAc variants in a curated pneumococcal genome database.
Results
The cPS biochemical structures of 15A, 15F, 15D and a novel type 15z differed according to their unique OAc pattern. While available serotyping antisera distinguished capsule types 15D from 15A and 15z from 15F, capsule types 15F/15D and 15z/15A were indistinguishable. We identified serotype “15A” and “15F” isolates molecularly typed as “15F” in prior work, but predicted to encode 15z or 15D cPS according to their OAcT gene content.
Conclusions
15D and 15z cPS contain either WciZ-mediated or WcjE-mediated O-acetylation, respectively, while 15F contains both. Current typing schemes may not reliably resolve variants of vaccine serotypes, but we highlight how an anticipatory approach to capsule type discovery can address typing blind spots and refine vaccine surveillance efforts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Instituto Biomédico, Universidade Federal Fluminense, Alameda Barros Terra, S/N, São Domingos, Niterói, RJ, 24020-150, Brazil.
ORCID-Profile: Kyle J Sahlberg, Feroze A Ganaie, Filipe Martire de Miranda, Juan J Calix
Zitieren
APA
Sahlberg, K. J., Ganaie, F. A., Martire de Miranda, F., Nahm, M. H., & Calix, J. J. (2026). O-acetylation mediates four distinct structural variants of the pneumococcal vaccine serotype 15A capsule polysaccharide. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag551
Vancouver
Sahlberg KJ, Ganaie FA, Martire de Miranda F, Nahm MH, Calix JJ. O-acetylation mediates four distinct structural variants of the pneumococcal vaccine serotype 15A capsule polysaccharide. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag551
BibTeX
@article{Sahlberg2026,
author = {Sahlberg, Kyle J and Ganaie, Feroze A and Martire de Miranda, Filipe and Nahm, Moon H and Calix, Juan J},
title = {O-acetylation mediates four distinct structural variants of the pneumococcal vaccine serotype 15A capsule polysaccharide},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag551}
}
EUVIMED